PYX Resources: Achieving volume and diversification milestones. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBYOT.L Regulatory News (BYOT)

  • There is currently no data for BYOT

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

NEW GLOBAL CONTRACT

4 Jun 2007 07:00

Byotrol PLC04 June 2007 BYOTROL NEW GLOBAL CONTRACT ANNOUNCEMENT The Directors of Byotrol plc (the "Company") are pleased to be able to report anew global contract that has been secured by the Company. The Company has worked in partnership to develop a range of productsincorporating Byotrol(R) technology for Fellowes Inc, a leading global providerof office accessories and business machines. As a global provider, Fellowes has access to a wide range of disinfectanttechnologies and chose Byotrol for its residual efficacy, ultra low toxicityprofile and broadband action against a wide range of micro-organisms. Fellowes is launching the Virashield(TM) range of products containing Byotrolacross Europe with a global launch planned in the near future. The range, whichincludes wipes and hand protection foam, is designed to help combat the spreadof infections in the workplace. Virashield(TM) offers both residual efficacy ofup to seven days coupled with broad spectrum capability against a wide range oforganisms including viruses such as influenza and avian flu and bacteriaincluding E.coli. Research has shown that a typical office desk harbours up to400 times more bacteria than a typical toilet seat and the residual efficacyoffered by the Virashield range containing Byotrol will help office workerscombat this real and growing risk of infection. The Virashield(TM) range has been extensively tested by both Byotrol andFellowes and the tests have proven the product's efficacy for up to seven daysfollowing application. The range can both remove microbes from surfaces in anoffice environment and keep the surface microbially clean for this period oftime. Byotrol plc Chief Executive David McRobbie said, "We are delighted to havesecured our first contract that will make Byotrol available on a global basisand that a company the size of Fellowes chose Byotrol as its worldwide strategicpartner for this key product launch. There is growing awareness thatmicro-organisms are not just an issue in hospitals and specialist environmentsand that effective cleaning regimes have a role in a wider range of settings." Headquartered in Illinois, USA with subsidiaries in Canada, Benelux, France,Germany, Italy, Poland, Spain, UK, China, Singapore, Japan, Korea and Australia,they have an extensive distribution & export network reaching over 100countries. Fellowes employs more than 2,700 people throughout the world andexpects global sales in excess of $700 million this year. Enquiries: Byotrol plc 0161 277 9518Stephen Falder Deputy Chairman Richard Bell 07825 204 110Finance Director Charles Stanley Securities 020 7149 6457Philip Davies McCann Erickson PR 01625 822540Jim Rothnie Rawlings Financial 01756 770376John Rawlings This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
6th Apr 202010:56 amRNSHolding(s) in Company
2nd Apr 202011:05 amRNSSecond Price Monitoring Extn
2nd Apr 202011:00 amRNSPrice Monitoring Extension
24th Mar 20209:05 amRNSSecond Price Monitoring Extn
24th Mar 20209:00 amRNSPrice Monitoring Extension
23rd Mar 20207:01 amRNSTrading Update
23rd Mar 20207:00 amRNSLicence and Product Supply Agreement with Tristel
16th Mar 20204:43 pmRNSSecond Price Monitoring Extn
16th Mar 20204:38 pmRNSPrice Monitoring Extension
13th Mar 20202:05 pmRNSSecond Price Monitoring Extn
13th Mar 20202:00 pmRNSPrice Monitoring Extension
28th Feb 20204:41 pmRNSSecond Price Monitoring Extn
28th Feb 20204:36 pmRNSPrice Monitoring Extension
28th Feb 20204:15 pmRNSHolding(s) in Company
30th Jan 20205:00 pmRNSDirector/PDMR Shareholding
30th Jan 20208:00 amRNSAcceleration of earn-out relating to Medimark
19th Dec 20197:00 amRNSInterim Results
14th Nov 201912:30 pmRNSResult of AGM
13th Nov 20197:00 amRNSHolding(s) in Company
8th Nov 20192:54 pmRNSHolding(s) in Company
11th Oct 20193:00 pmRNSRestoration - Byotrol Plc
11th Oct 20193:00 pmRNSPosting of Accounts, Notice of AGM and Restoration
1st Oct 20193:50 pmRNSHolding(s) in Company
1st Oct 20197:30 amRNSSuspension - BYOTROL PLC
30th Sep 201912:01 pmRNSPublication of accounts and temporary suspension
30th Sep 201912:00 pmRNSUnaudited Preliminary Results to 31 March 2019
25th Sep 20197:00 amRNSNotice of Results
3rd Sep 20199:08 amRNSNotice of Results
28th May 20197:00 amRNSAppointment of CFO & Award of Options
9th May 20197:00 amRNSTrading Update
15th Apr 201911:58 amRNSHolding(s) in Company
28th Feb 20197:00 amRNSEPA Approval and Target Roll-Out
31st Jan 20199:14 amRNSHolding(s) in Company
29th Jan 20197:00 amRNSAppointment of New Director & Award of Options
31st Dec 20187:00 amRNSGrant of Options
21st Dec 20181:41 pmRNSHolding(s) in Company
21st Dec 20181:41 pmRNSHolding(s) in Company
20th Dec 201812:07 pmRNSDirector Dealings
18th Dec 20187:00 amRNSInterim Results
14th Nov 201810:35 amRNSHolding(s) in Company
13th Nov 20184:00 pmRNSHolding(s) in Company
13th Nov 201811:20 amRNSDirector/PDMR Shareholding
12th Nov 20185:05 pmRNSHolding(s) in Company
21st Sep 20184:00 pmRNSResult of AGM
4th Sep 201811:15 amRNSPosting of Annual Report and Notice of AGM
3rd Sep 20184:48 pmRNSHolding(s) in Company
3rd Sep 20184:12 pmRNSHolding(s) in Company
24th Aug 201812:01 pmRNSDirector Dealing
24th Aug 20187:00 amRNSDirector Dealing
23rd Aug 201811:31 amRNSAcquisition of Medimark Scientific Limited

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.